Johannsson, G <br/><br/>
Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency.  [electronic resource] 

 -  Journal of endocrinological investigation  Aug 2018 
 - 919-927 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1720-8386 
<br/><br/><label>Standard No.: </label>10.1007/s40618-017-0818-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Neutralizing--chemistry<br/>Biological Availability<br/>Biomarkers--analysis<br/>Female<br/>Follow-Up Studies<br/>Growth Disorders--drug therapy<br/>Human Growth Hormone--administration & dosage<br/>Humans<br/>Lipids--chemistry<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Recombinant Proteins--administration & dosage<br/>Young Adult